Ceros Capital Markets - Institutional Quality Deals for Investors

Three Key Considerations To Secure Funding

There is capital sitting on the sidelines, but founders and CEOs should realize that investors are digging into their due diligence. The “wow” factor and potential size of the medtech market matter much less now than solid fundamentals.

DERMASENSOR

DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event

DermaSensor Inc. — the creator of a handheld, point-and-click device to quickly assess skin lesions for cancer risk — is the winner of the MedTech Innovator Mid-Stage Companies Pitch Event.

DERMASENSOR

DermaSensor raises $10M, completes pivotal FDA studies for its skin cancer detection device

(RefreshMiami) Today, DermaSensor is announcing that it has closed a $10 million round of financing, led by existing investors including Ceros Capital Markets.

CEROS

As Markets Reel, Startups Hope for ‘Flat’ Rounds

(WSJ) The froth of past valuations has waned. If a startup manages to get the same per-share price of its previous funding—a flat round—it’s a win. ‘Flat is the new up,’ says one startup CEO

PRISTINE SURGICAL

Ceros Financial Services Arranges $15 Million Financing for Pristine Surgical

Ceros, focused on early-stage medtech, completes placement for Single-use visualization platform

AQUYRE BIOSCIENCES

Ceros Financial Services Arranges $17.14 Million Financing of Aquyre Biosciences

Ceros focuses on investment in emerging medical technology companies.

CEROS

Medical-Device IPOs, Acquisitions Jumped in 2021

(WSJ) Medical-device startups staged 24 IPOs last year, the highest number on record

CEROS

Healthtech to Benefit from Changed Consumer Behavior

Ceros Financial Services CEO Mark Goldwasser is banking on new health behaviors to drive healthtech in 2022.

CEROS

Why Ceros Focuses on Funding Medical Technology Start-ups

(InfoMedTechNews) With about $117 million in transactions by the end of 2021, Ceros Financial Services is building an investment banking platform focused on fundraising for early-stage medical technology and medical device companies.

CEROS

ProMIS Neurosciences Closes Upsized US$20,125,000 Public Offering

(Yahoo Finance) ...and Ceros Financial Services, Inc. acted as the exclusive sub-agent for the sale of Units in certain jurisdictions....

MEMIC

Robotics Firm Memic Is in Talks to Go Public Via SPAC

(Bloomberg) Memic Innovative Surgery, a medical-device company that specializes in robot-assisted surgery, is in talks to go public through a merger with MedTech Acquisition Corp., a blank-check firm, according to people with knowledge of the matter.

CEROS

Maurice R. Ferré’s Firm Making ‘Humanoid’-like Surgery Robots Acquired for $1B value

(Miami Herald) Dr. Maurice R. Ferré has helped mint the third $1 billion company with the announcement Friday that Memic, a robotic surgery company that he chairs, has been acquired by...

CEROS

Startup Medical-Device Acquisitions Picked Up in First Half of Year

(Wallstreet Journal) Medical-technology companies are buying more startups as the industry recovers from disruptions to healthcare procedures triggered by the global pandemic last year....

DERMASENSOR

Dermasensor Raises $11.5 Million In Series A Round

(RefreshMiami) On the road to bringing its first device to market, DermaSensor, a Miami-based health-tech company designing tools to better equip primary care providers for skin cancer checks, today announced…

MEMIC

Memic Raises $96M for it’s Robot-assisted Surgery Platform

(TechCrunch) Memic, a startup developing a robotic-assisted surgical platform that recently received marketing authorization from the U.S. Food and Drug Administration, today announced that it has closed a $96 million Series D funding round.

CEROS

Latest New York transplant: $100 million in investments for South Florida medtech companies

(Miami Herald) Latest to join is Ceros Financial Services, a financial advisory group that is raising $100 million over the next 12 months to fund emerging medical technology companies in South Florida and beyond.

MEMIC

Memic, a Medical Device Company Chaired by Maurice R. Ferré, Raises $96 Million

(Refresh Miami) Memic Innovative Surgery, a medical device company, today announced it has closed a $96 million Series D financing round. The company, based in Tel Aviv and Fort Lauderdale, has another South Florida tie:

CEROS

Medtech Funder Ceros Moving to Miami, Aiming to invest $100M

(RefreshMiami) A medical device company based in Fort Lauderdale and Tel Aviv that is chaired by Miami serial entrepreneur Maurice R. Ferré, closed a $96 million Series D financing round.

Three Key Considerations To Secure Funding

DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event

DermaSensor raises $10M, completes pivotal FDA studies for its skin cancer detection device

As Markets Reel, Startups Hope for ‘Flat’ Rounds

Ceros Financial Services Arranges $15 Million Financing for Pristine Surgical

Ceros Financial Services Arranges $17.14 Million Financing of Aquyre Biosciences

Medical-Device IPOs, Acquisitions Jumped in 2021

Healthtech to Benefit from Changed Consumer Behavior

Why Ceros Focuses on Funding Medical Technology Start-ups

ProMIS Neurosciences Closes Upsized US$20,125,000 Public Offering

Robotics Firm Memic Is in Talks to Go Public Via SPAC

Maurice R. Ferré’s Firm Making ‘Humanoid’-like Surgery Robots Acquired for $1B value

Startup Medical-Device Acquisitions Picked Up in First Half of Year

Dermasensor Raises $11.5 Million In Series A Round

Memic Raises $96M for it’s Robot-assisted Surgery Platform

Latest New York transplant: $100 million in investments for South Florida medtech companies

Memic, a Medical Device Company Chaired by Maurice R. Ferré, Raises $96 Million

Medtech Funder Ceros Moving to Miami, Aiming to invest $100M

Share